GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's administration, according to Emma Walmsley, the outgoing chief executive officer of the ...
If you’ve joined us at a Women, Money & Power conference or participated in the New Voices initiative, you’re part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback